Clinical Trials Browser

sintilimab × Tumor-Agnostic × 30 days × Clear all

NCT07455617 2026-03-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

Phase 1 Not yet recruiting

Neoplasm Metastasis

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary